On-treatment platelet reactivity in patients with chronic obstructive pulmonary disease undergoing percutaneous coronary intervention

Thorax

Volumn 69, Issue 1, 2014, Pages 80-81

  Campo, Gianluca ^a,b   Pavasini, Rita ^a   Pollina, Alberto ^a   Tebaldi, Matteo ^a   Ferrari, Roberto ^a,b  

^a Azienda Ospedaliera Universitaria   (Italy)

^b LTTA Center   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CYTOCHROME P450 2C19; MULTIDRUG RESISTANCE PROTEIN 1;

ABCB1 GENE; ACUTE CORONARY SYNDROME; AGED; ARTICLE; CARDIOVASCULAR STENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; CYP2C19 GENE; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET REACTIVITY; PON1 GENE; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME;

COPD EPIDEMIOLOGY;

AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84890315290     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2013-203608     Document Type: Article

References (5)

1. Campo G, Guastaroba P, Marzocchi A, et al. Impact of chronic obstructive pulmonary disease on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest 2013. doi: 10.1378/chest.12-2313. [Epub ahead of print].
2. Valgimigli M, Campo G, Monti M, et al. Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial. Circulation 2012;125:2015-26.
3. Campo G, Ferraresi P, Marchesini J, et al. Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention. J Thromb Haemost 2011;9:2106-18.
4. Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009;53:849-56.
5. Angiolillo DJ, Bernardo E, Capodanno D, et al. Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy. J Am Coll Cardiol 2010;55:1139-46.